Genomics and antimicrobial resistance

Already put to use in the worldwide search for new antimicrobial agents, genomics can also contribute to better targeted treatment 

Patient perspectives: the art of good communication

In the second article covering our recent patient panel event, we consider the issue that both panellists and audience members agreed was most important

Patient perspectives: managing expectations

Following our insightful patient panel event on 6th March, we explore the importance of preparing for the highs, and lows, of genomic testing

All I want for Christmas is... a family history

At a time of year when many of us will be getting together with relatives, we explore the value of talking about your family's health

Delivering results: the patient perspective

As genomic testing becomes more prevalent, the ability to deliver results sensitively is paramount; so what matters to your patients and their families?

Tuberculosis: genome sequencing and new treatment

TB cases are falling worldwide, but with hard-to-treat strains more prevalent than ever, how can genomics help? And what’s new on the treatment horizon?

Your invaluable genome

Genomic data is the currency of a new era of medicine that promises incredible advances. Here, bioinformatician Nana Mensah explains why

Building on the legacy of the 100,000 Genomes Project

As the pioneering project recruits its last participants, we look forward to the NHS’s plans for a Genomic Medicine Service for all

First RNA-based therapy approved in US and Europe

Gene-silencing technique works without altering the person’s DNA, and prevents harmful proteins from being made in their cells  

Rare disease, genomics and the future

In the run-up to Rare Disease Day, we outline what constitutes ‘rare’ and how genomics is used in diagnosis and management

Direct-to-consumer genetic tests at an all-time high…

… but how can healthcare professionals make sure they are equipped to support patients who are worried and distressed about their results?  
Rare-disease-family

UK rare disease strategy: the plan for implementation

Four years on from the government’s rare disease strategy, its implementation plan has been published. Here’s our summary of the key areas of focus